Literature DB >> 24815438

Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.

Xiao-Kui Tang1, Ke-Jian Wang, Yu-Kui Tang, Li Chen.   

Abstract

The aims of this study were to investigate the influence of ubiquitin- conjugating enzyme E2C (UBE2C) on biological behavior of lung cancer cells. Using MTT, flow cytometry and invasion assays, we detected UBE2C expression and evaluated its biological properties in these cells, including effects on proliferation, the cell cycle profile and invasive capability. Compared with control cells, the UBE2C transfected cells demonstrated increased cellular proliferation (p<0.05). UBE2C transfected cells also had a lower percentage in G1 phase and a higher percentage in S phase (p<0.05). Importantly, the UBE2C transfected cells had a notable enhancement of cell numbers penetrating the basement membrane compared with the control group (p<0.05). Ectopic up- regulation UBE2C promoted the growth of lung cancer cells in vivo. Furthermore, we found UBE2C increased the expression of cyclin D1 and MMP-2. These results show UBE2C may represent a potential therapeutic target for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815438     DOI: 10.7314/apjcp.2014.15.7.3005

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.

Authors:  Mohammad Ali Fahmidehkar; Sayed Mohammad Shafiee; Ebrahim Eftekhar; Laleh Mahbudi; Atefeh Seghatoleslam
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

2.  Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma.

Authors:  Meng-Chi Yen; Kuan-Li Wu; Yu-Wei Liu; Yung-Yun Chang; Chao-Yuan Chang; Jen-Yu Hung; Ying-Ming Tsai; Ya-Ling Hsu
Journal:  Biology (Basel)       Date:  2021-04-28

3.  Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.

Authors:  Donghai Xiong; Jing Pan; Qi Zhang; Eva Szabo; Mark Steven Miller; Ronald A Lubet; Ming You; Yian Wang
Journal:  Oncotarget       Date:  2017-03-21

4.  UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.

Authors:  Jun Zhang; Xinyu Liu; Guanzhen Yu; Lei Liu; Jiejun Wang; Xiaoyu Chen; Yuhai Bian; Yuan Ji; Xiaoyan Zhou; Yinan Chen; Jun Ji; Zhen Xiang; Lei Guo; Jingyuan Fang; Yihong Sun; Hui Cao; Zhenggang Zhu; Yingyan Yu
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

5.  The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.

Authors:  Yingying Gong; Danna Wang; Lu Lin; Junjun Dai; Lan Yu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.

Authors:  Yu Jiang; Yuan Huang; Yinhao Du; Yinjun Zhao; Jie Ren; Shuangge Ma; Cen Wu
Journal:  Cancer Inform       Date:  2020-12-10

7.  Identification of Ubiquitin-Related Gene-Pair Signatures for Predicting Tumor Microenvironment Infiltration and Drug Sensitivity of Lung Adenocarcinoma.

Authors:  Yumei Li; Lanfen An; Zhe Jia; Jingxia Li; E Zhou; Feng Wu; Zhengrong Yin; Wei Geng; Tingting Liao; Wenjing Xiao; Jingjing Deng; Wenjuan Chen; Minglei Li; Yang Jin
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

8.  The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.

Authors:  Chao-Hua Mo; Li Gao; Gang Chen; Zhen-Bo Feng; Xiao-Fei Zhu; Kang-Lai Wei; Jing-Jing Zeng
Journal:  Cancer Cell Int       Date:  2017-09-25       Impact factor: 5.722

9.  Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.

Authors:  Chen Huo; Meng-Yu Zhang; Rui Li; Xi-Jia Zhou; Ting-Ting Liu; Jian-Ping Li; Xiao Liu; Yi-Qing Qu
Journal:  Int J Med Sci       Date:  2020-09-01       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.